Evidence map›Paper›PMID 28605173›Full record

ReviewJournal of the International AIDS Society2017

Barriers to HIV remission research in low- and middle-income countries.

Theresa Rossouw, Joseph D Tucker, Gert U van Zyl, Kenly Sikwesi, Catherine Godfrey

Open access · goldAbstract readReview
In one paragraph

Review in Journal of the International AIDS Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Minimally Invasive Tissue Sampling: A Tool to Guide Efforts to Reduce AIDS-Related Mortality in Resource-Limited Settings.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Ethical issues in HIV remission trials.Current opinion in HIV and AIDS · 2018
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Theresa RossouwInstitute for Cellular and Molecular Medicine, Department of Immunology, University of Pretoria South Africa, Pretoria, Republic of South Africa.
Joseph D TuckerInstitute for Global Health and Infectious Diseases, UNC Chapel Hill, Chapel Hill, NC, USA.
Gert U van ZylDivision of Medical Virology, Stellenbosch University and NHLS Tygerberg, Cape Town, South Africa.
Kenly SikwesiCoordinator of the African Community Advisory Board (AFROCAB), Lusaka, Zambia.
Catherine GodfreyNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
National Health Laboratory Service · ZANational Institute of Allergy and Infectious Diseases · USUniversity of North Carolina at Chapel Hill · USUniversity of Pretoria · ZA

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Unintended and Intended Implications of HIV Cure: A Social and Ethical AnalysisR01AI108366 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RENNIE, STUART, TUCKER, JOSEPH DAVID · 2013 to 2017
$2.9M
NIAID NIH HHS P30 AI050410NIAID NIH HHS R01 AI108366
6 · The paper itself

Abstract

introductionHIV eradication and remission research has largely taken place in high-income countries. In low- and middle-income countries (LMIC), there may be factors that have a substantial impact on the size of the latent HIV reservoir and the immunological response to infection. If a curative strategy is to be available to all HIV-infected individuals, these factors must be understood.

methodsWe use a scoping review to examine the literature on biological factors that may have an impact on HIV persistence in LMIC. Three databases were searched without date restrictions.

resultsUncontrolled viral replication and higher coinfection prevalence may alter the immunological milieu of individuals in LMIC and increase the size of the HIV reservoir. Differences in HIV subtype could also influence the measurement and size of the HIV reservoir. Immune activation may differ due to late presentation to care, presence of chronic infections, increased gut translocation of bacterial products and poor nutrition.

conclusionsResearch on HIV remission is urgently needed in LMIC. Research into chronic immune activation in resource poor environments, the immune response to infection, the mechanisms of HIV persistence and latency in different viral clades and the effect of the microbiological milieu must be performed. Geographic differences, which may be substantial and may delay access to curative strategies, should be identified.

Indexed as

PovertyAnti-HIV AgentsCoinfectionEconomicsHIV InfectionsHumansIncomePrevalenceVirus ReplicationAnti-HIV AgentsHIV cureHIV eradicationHIV remissionimmune systemlow- and middle-income countriesresource limited

Identifiers

PMID28605173
PMCPMC5515034
OpenAlexW2620780729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.